These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31290719)

  • 1. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
    Peng J; Yang X; Li X; Gao H; Liu N; Guo X
    Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
    Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
    Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
    Lin X; Tang X; Zheng T; Qiu J; Hua K
    J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
    Zhang H; Dong R; Zhang P; Wang Y
    Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation.
    McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK
    Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
    Yagi H; Yotsumoto F; Miyamoto S
    Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
    Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleuromutilin Inhibits Proliferation and Migration of A2780 and Caov-3 Ovarian Carcinoma Cells and Growth of Mouse A2780 Tumor Xenografts by Down-Regulation of pFAK2.
    Zhang B; Ma X; Li Y; Li S; Cheng J
    Med Sci Monit; 2020 Feb; 26():e920407. PubMed ID: 32041931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.
    Zhu Q; Tang M; Wang X
    Cancer Biol Ther; 2017 Apr; 18(4):222-228. PubMed ID: 28278071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
    Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
    Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance.
    Wang D; Zhang L; Hu A; Wang Y; Liu Y; Yang J; Du N; An X; Wu C; Liu C
    Protein Cell; 2021 Feb; 12(2):107-127. PubMed ID: 32448967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits the development and metastasis of ovarian cancer.
    Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
    Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.